Literature DB >> 30219185

Whole-Body MR Imaging: The Novel, "Intrinsically Hybrid," Approach to Metastases, Myeloma, Lymphoma, in Bones and Beyond.

Frederic E Lecouvet1, Sandy Van Nieuwenhove2, François Jamar3, Renaud Lhommel3, Ali Guermazi4, Vassiliki P Pasoglou2.   

Abstract

Whole-body MR imaging (WB-MR imaging) has become a modality of choice for detecting bone metastases in multiple cancers, and bone marrow involvement by multiple myeloma or lymphoma. Combination of anatomic and functional sequences imparts an inherently hybrid dimension to this nonirradiating tool and extends the screening of malignancies outside the skeleton. WB-MR imaging outperforms bone scintigraphy and CT and offers an alternative to PET in many tumors by time of lesion detection and assessment of treatment response. Much work has been done to standardize procedures, optimize sequences, validate indications, confirm preliminary research into new applications, rendering clinical application more user-friendly.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone metastases; DWI; PET; Rheumatology; WB-MR imaging

Mesh:

Substances:

Year:  2018        PMID: 30219185     DOI: 10.1016/j.cpet.2018.05.006

Source DB:  PubMed          Journal:  PET Clin        ISSN: 1556-8598


  3 in total

1.  Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study.

Authors:  Nicolas F Michoux; Jakub W Ceranka; Jef Vandemeulebroucke; Frank Peeters; Pierre Lu; Julie Absil; Perrine Triqueneaux; Yan Liu; Laurence Collette; Inneke Willekens; Carola Brussaard; Olivier Debeir; Stephan Hahn; Hubert Raeymaekers; Johan de Mey; Thierry Metens; Frédéric E Lecouvet
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

Review 2.  Improving protocols for whole-body magnetic resonance imaging: oncological and inflammatory applications.

Authors:  Mareen S Kraus; Ayat A Yousef; Sandra L Cote; Mary-Louise C Greer
Journal:  Pediatr Radiol       Date:  2022-08-19

Review 3.  Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging.

Authors:  Karla M Treitl; Jens Ricke; Andrea Baur-Melnyk
Journal:  Skeletal Radiol       Date:  2021-05-24       Impact factor: 2.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.